Stable isotope-based flux studies in nonalcoholic fatty liver disease.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pharmacology and Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.pharmthera.2017.07.008PMID 28720429PMCID PMC5743607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies.

  2017cited by this paper
• Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease

  2017cited by this paper
• The development of a non‐invasive model to predict the presence of non‐alcoholic steatohepatitis in patients with non‐alcoholic fatty liver disease

  2016cited by this paper
• Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.

  2016cited by this paper
• A Western diet induced NAFLD in LDLR(-/)(-) mice is associated with reduced hepatic glutathione synthesis.

  2016cited by this paper
• Assessment of Hepatic Mitochondrial Oxidation and Pyruvate Cycling in NAFLD by (13)C Magnetic Resonance Spectroscopy.

  2016cited by this paper
• Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.

  2016cited by this paper
• Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.

  2016cited by this paper
• Nonalcoholic Fatty Liver Disease in Children: Role of the Gut Microbiota

  2016cited by this paper
• Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood

  2016cited by this paper
• Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

  2016cited by this paper
• Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD.

  2016cited by this paper
• Natural History of Nonalcoholic Fatty Liver Disease

  2016cited by this paper
• Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

  2016cited by this paper
• Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.

  2015cited by this paper
• Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta‐analysis

  2015cited by this paper
• Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.

  2015cited by this paper
• Tracer-based assessments of hepatic anaplerotic and TCA cycle flux: practicality, stoichiometry, and hidden assumptions.

  2015cited by this paper
• Turnover Rates of Hepatic Collagen and Circulating Collagen-Associated Proteins in Humans with Chronic Liver Disease

  2015cited by this paper
• Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

  2015cited by this paper
• Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men.

  2015cited by this paper
• Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

  2015cited by this paper
• Monitoring newly synthesized proteins over the adult life span of Caenorhabditis elegans.

  2015cited by this paper
• Tracer-based estimates of protein flux in cases of incomplete product renewal: evidence and implications of heterogeneity in collagen turnover.

  2015cited by this paper
• Influence of Liver Triglycerides on Suppression of Glucose Production by Insulin in Men

  2014cited by this paper
• Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

  2014cited by this paper
• Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis

  2014influential reference
• A validation of the application of D(2)O stable isotope tracer techniques for monitoring day-to-day changes in muscle protein subfraction synthesis in humans.

  2014cited by this paper
• Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study

  2014cited by this paper
• Glycine restores glutathione and protects against oxidative stress in vascular tissue from sucrose-fed rats.

  2014cited by this paper
• Energy metabolism in the liver.

  2014influential reference
• Noninvasive in vivo magnetic resonance measures of glutathione synthesis in human and rat liver as an oxidative stress biomarker

  2014cited by this paper
• Dynamic carbon 13 breath tests for the study of liver function and gastric emptying

  2014cited by this paper
• The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

  2014cited by this paper
• Mitochondria in Cardiovascular Physiology and Disease Assessment of cardiac proteome dynamics with heavy water : slower protein synthesis rates in interfibrillar than subsarcolemmal mitochondria

  2013cited by this paper
• Assessment of cardiac proteome dynamics with heavy water: slower protein synthesis rates in interfibrillar than subsarcolemmal mitochondria.

  2013cited by this paper
• Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy

  2013cited by this paper
• Role of ceramides in nonalcoholic fatty liver disease.

  2012cited by this paper
• Interplay between lipids and branched-chain amino acids in development of insulin resistance.

  2012cited by this paper
• Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity.

  2012cited by this paper
• Skeletal Muscle Insulin Resistance Promotes Increased Hepatic De Novo Lipogenesis, Hyperlipidemia, and Hepatic Steatosis in the Elderly

  2012cited by this paper
• Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data

  2012cited by this paper
• Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia

  2012cited by this paper
• Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease

  2012cited by this paper
• Proteome Dynamics: Revisiting Turnover with a Global Perspective*

  2012cited by this paper
• Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease.

  2011cited by this paper
• Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

  2011cited by this paper
• The non-invasive 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis

  2011cited by this paper
• Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.

  2011cited by this paper
• The Role of Lipid Metabolism in the Pathogenesis of Alcoholic and Nonalcoholic Hepatic Steatosis

  2010cited by this paper
• Evaluation of the 13C-Octanoate Breath Test as a Surrogate Marker of Liver Damage in Animal Models

  2010cited by this paper
• Nonalcoholic Fatty Liver Disease as the Transducer of Hepatic Oversecretion of Very-Low-Density Lipoprotein–Apolipoprotein B-100 in Obesity

  2010cited by this paper
• Glutathione Synthesis Is Diminished in Patients With Uncontrolled Diabetes and Restored by Dietary Supplementation With Cysteine and Glycine

  2010cited by this paper
• Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

  2010cited by this paper
• Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model.

  2010cited by this paper
• Differential expression of lumican and fatty acid binding protein‐1: New insights into the histologic spectrum of nonalcoholic fatty liver disease

  2009cited by this paper
• Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.

  2009cited by this paper
• Liver fat and lipid oxidation in humans

  2009cited by this paper
• Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

  2009cited by this paper
• Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion.

  2009cited by this paper
• Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

  2008cited by this paper
• The many intersecting pathways underlying apolipoprotein B secretion and degradation.

  2008cited by this paper
• Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

  2008cited by this paper
• Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future

  2007cited by this paper
• Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

  2007cited by this paper
• Hepatic histology in obese patients undergoing bariatric surgery.

  2006cited by this paper
• Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.

  2006cited by this paper
• Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis.

  2006cited by this paper
• Peroxisomes and oxidative stress.

  2006cited by this paper
• Ceramides in insulin resistance and lipotoxicity.

  2006cited by this paper
• In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

  2006cited by this paper
• Prevalence and Predictive Factors of Non-Alcoholic Steatohepatitis (NASH) in Morbidly Obese Patients Undergoing Bariatric Surgery

  2006cited by this paper
• Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men.

  2005cited by this paper
• Probing peroxisomal β-oxidation and the labelling of acetyl-CoA proxies with [1-13C]octanoate and [3-13C]octanoate in the perfused rat liver

  2005cited by this paper
• Probing peroxisomal beta-oxidation and the labelling of acetyl-CoA proxies with [1-(13C)]octanoate and [3-(13C)]octanoate in the perfused rat liver.

  2005cited by this paper
• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

  2005cited by this paper
• Total body metabolism of 13C-octanoic acid is preserved in patients with non-alcoholic steatohepatitis, but differs between women and men

  2005cited by this paper
• The Importance of Routine Liver Biopsy in Diagnosing Nonalcoholic Steatohepatitis in Bariatric Patients

  2004cited by this paper
• Non‐alcoholic steatohepatitis in type 2 diabetes mellitus

  2004cited by this paper
• Nonalcoholic steatohepatitis

  2004cited by this paper
• In Vitro Modeling of Fatty Acid Synthesis under Conditions Simulating the Zonation of Lipogenic [13C]Acetyl-CoA Enrichment in the Liver*[boxs]

  2004cited by this paper
• Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease.

  2003cited by this paper
• Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

  2003cited by this paper
• Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test

  2003cited by this paper
• Oxidative breakdown of octanoic acid is maintained in patients with cirrhosis despite advanced disease

  2003cited by this paper
• The metabolic abnormalities associated with non-alcoholic fatty liver disease.

  2002cited by this paper
• Complexity in the Secretory Pathway: The Assembly and Secretion of Apolipoprotein B-containing Lipoproteins*

  2002cited by this paper
• Apolipoprotein synthesis in nonalcoholic steatohepatitis

  2002cited by this paper
• Update on nonalcoholic fatty liver disease.

  2002influential reference
• Redox Regulation of Cytokine Expression in Kupffer Cells

  2002cited by this paper
• A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver

  2001cited by this paper
• Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

  2001cited by this paper
• Mobilisation of triacylglycerol stores.

  2000cited by this paper
• Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model.

  2000cited by this paper
• Mitochondrial abnormalities in non-alcoholic steatohepatitis.

  1999cited by this paper
• Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus*

  1999cited by this paper
• Quantifying gluconeogenesis during fasting.

  1997cited by this paper
• Quantifying gluconeogenesis during fasting.

  1997cited by this paper
• Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state.

  1995cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper

• Paving the way for improved action: how nuclear techniques can advance the assessment of malnutrition.

  2025cites this paper
• Detecting altered hepatic lipid oxidation by MRI in an animal model of MASLD

  2024cites this paper
• Detecting altered hepatic lipid oxidation by MRI in an animal model of NAFLD

  2023cites this paper
• Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD

  2023cites this paper
• Perspectives on diacylglycerol-induced improvement of insulin sensitivity in type 2 diabetes

  2022cites this paper
• Adipose tissue dysfunction and visceral fat are associated to hepatic insulin resistance and severity of NASH even in lean individuals

  2022cites this paper
• Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

  2021cites this paper
• Metabolic and genetic contributions to NAFLD: really distinct and homogeneous?

  2021cites this paper
• Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent.

  2021cites this paper
• Measuring Acetyl-CoA and Acetylated Histone Turnover in vivo: Effect of a High Fat Diet.

  2020cites this paper
• Childhood severe acute malnutrition is associated with metabolomic changes in adulthood

  2020cites this paper
• HDL Flux is Higher in Patients with Nonalcoholic Fatty Liver Disease.

  2019cites this paper
• Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver.

  2019cites this paper
• Dietary fatty acid oxidation is decreased in non‐alcoholic fatty liver disease: A palmitate breath test study

  2019cites this paper